ACELYRIN, Inc. Contracts & Agreements
22 Contracts & Agreements
- Business Finance (6 contracts)
- Business Operations (2)
- Human Resources (11)
- Intellectual Property (1)
- Mergers & Acquisitions (1)
- Uncategorized (1)
- Separation Agreement and Mutual Release between the Company and Shao-Lee Lin, M.D., Ph.D (Filed With SEC on May 9, 2024)
- Separation Agreement and Mutual Release between the Company and Ron Oyston (Filed With SEC on May 9, 2024)
- Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 28, 2024)
- Separation Agreement and Release (Filed With SEC on August 2, 2023)
- Form of Underwriting Agreement (Filed With SEC on May 1, 2023)
- Form of Common Stock Certificate of the Registrant (Filed With SEC on May 1, 2023)
- ACELYRIN, INC. 2023 Equity Incentive Plan (Filed With SEC on May 1, 2023)
- Forms of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the ACELYRIN, INC. 2023 Equity Incentive Plan (Filed With SEC on May 1, 2023)
- Forms of Restricted Stock Unit Grant Notice and Award Agreement under the ACELYRIN, INC. 2023 Equity Incentive Plan (Filed With SEC on May 1, 2023)
- ACELYRIN, INC. 2023 Employee Stock Purchase Plan (Filed With SEC on May 1, 2023)
- ACELYRIN, INC. 2023 Non-Employee Director Compensation Policy (Filed With SEC on May 1, 2023)
- ACELYRIN, INC. Severance Plan (Filed With SEC on May 1, 2023)
- Form of Indemnification Agreement by and between the Registrant and its directors and executive officers (Filed With SEC on May 1, 2023)
- Form of Employment Agreement for Executive Officers (Filed With SEC on May 1, 2023)
- ACELYRIN, INC. Cash Incentive Plan (Filed With SEC on May 1, 2023)
- Agreement and Plan of Merger and Reorganization by and among the Registrant, ValenzaBio, Inc., WH1, INC., WH2, LLC and Seller Representatives LLC dated December 20, 2022 (Filed With SEC on April 13, 2023)
- Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated September 9, 2022 (Filed With SEC on April 13, 2023)
- ACELYRIN, INC. 2020 Stock Option and Grant Plan, as amended (Filed With SEC on April 13, 2023)
- Forms of Non-Qualified Stock Option Grant Notice, Non-Qualified Stock Option Grant Notice-Non-U.S., Early Exercise Non-Qualified Stock Option Grant Notice, Incentive Stock Option... (Filed With SEC on April 13, 2023)
- ValenzaBio, Inc. Stock Plan and forms thereunder (Filed With SEC on April 13, 2023)
- License and Collaboration Agreement by and between the Registrant and Affibody AB, dated August 9, 2021, as amended (Filed With SEC on April 13, 2023)
- License and Commercialization Agreement by and between ValenzaBio Inc. and Pierre Fabre Medicament SAS, dated March 25, 2021, as amended (Filed With SEC on April 13, 2023)
